---
title: "Moderate-to-vigorous physical activity and reduced adiposity and obesity risk in older adults at h"
id: "medrxiv-13-moderate-to-vigorous-physical-activity-age-dependent-adiposity-and-obesity-risk"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-13-moderate-to-vigorous-physical-activity-age-dependent-adiposity-and-obesity-risk"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1?rss=1"
published_at: "2026-09-15T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Moderate-to-vigorous physical activity and reduced adiposity and obesity risk in older adults at h
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-13-moderate-to-vigorous-physical-activity-age-dependent-adiposity-and-obesity-risk
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1?rss=1)
- **Published At:** 2026-09-15T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Study population: PREDIMED participants aged 60–80 years at high cardiovascular risk; 61% women; sample sizes were n=5,273 for BMI analyses and n=4,940 for WHtR analyses. - Exposure: Usual **moderate-to-vigorous physical activity** during leisure time (MVLTPA) assessed with the Minnesota questionnaire and expressed as MET-min/day; cumulative mean used. - MVLTPA threshold: Participants classified as having **adequate MVLTPA** (≥100 MET-min/day) versus **insufficient MVLTPA** (<100 MET-min/day). - Outcomes: Longitudinal trajectories of **BMI** and **waist-to-height ratio (WHtR)**; incident obesity (BMI ≥30 kg/m2) and central adiposity (WHtR ≥0.6). - Statistical methods: Mixed-effects models with cubic splines to estimate BMI and WHtR trajectories by MVLTPA level; Cox proportional hazards models for incident outcomes. - Main findings: Participants with ≥100 MET-min/day had lower BMI (difference range −1.27 to −1.48 kg/m2) and lower WHtR (difference range −0.021 to −0.026) compared with less active individuals, and experienced slower BMI declines over time. - Incident risk: Adequate MVLTPA associated with a 34% lower risk of **central adiposity** (HR 0.66; 95% CI 0.56–0.77). - Sex-specific result: Adequate MVLTPA was linked to a 24% lower risk of obesity in women (HR 0.76; 95% CI 0.57–1.00); p-interaction for sex = 0.084. - Dose–response: Nonlinear analysis indicated central adiposity risk decreased up to ~400 MET-min/day and plateaued beyond that level. - Data/code: Individual-level data not public due to privacy; analysis code available at the cited GitHub repository. - Ethics and approvals: Study approved by Parc de Salut Mar Ethics Committee (reference provided); participants provided written informed consent; conducted per Declaration of Helsinki. - Conflicts: Several authors reported personal fees, grants, or board roles with food or industry groups; remaining authors declared no conflicts.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=ot5cCJEvKL3v4DkUynAxVbP6QXxxLHIDND_JNq4azbU-1789516114.6063285-1.2.1.1-rs83Iy9z6_nvKh9owfGqdMPAY8cuDozjywFwzBtFW2_pfeNk2aDNG7Kub7pLTu68) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Moderate-to-vigorous physical activity, age-dependent adiposity, and obesity risk in older adults at high cardiovascular risk Eleonora Fornara, [ View ORCID Profile](http://orcid.org/0000-0002-6983-413X)Marta H Hernandez, Alberto Goday, Anna Camps-Vilaro, Miguel Angel Martinez-Gonzalez, [ View ORCID Profile](http://orcid.org/0000-0003-2700-7459)Jordi Salas-Salvado, Ramon Estruch, Emilio Ros, Raquel Cueto-Galan, Miquel Fiol, Jose Lapetra, Juan Timiraos, Lluis Serra-Majem, Xavier Pinto, Zenaida Vazquez-Ruiz, Francisco Javier Martin-Lujan, Montserrat Fito, [ View ORCID Profile](http://orcid.org/0000-0001-8593-1477)Alvaro Hernaez doi: https://doi.org/10.64898/2026.09.14.26362982 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Eleonora Fornara 1 Hospital del Mar Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Eleonora%2BFornara%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fornara%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEleonora%2BFornara%2B) Marta H Hernandez 2 Blanquerna School of Health Sciences; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marta%2BH%2BHernandez%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hernandez%20MH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMarta%2BH%2BHernandez%2B) * [ORCID record for Marta H Hernandez](http://orcid.org/0000-0002-6983-413X "Open in new tab") Alberto Goday 3 Hospital del Mar; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alberto%2BGoday%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Goday%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlberto%2BGoday%2B) Anna Camps-Vilaro 1 Hospital del Mar Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anna%2BCamps-Vilaro%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Camps-Vilaro%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnna%2BCamps-Vilaro%2B) Miguel Angel Martinez-Gonzalez 4 University of Navarra; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Miguel%2BAngel%2BMartinez-Gonzalez%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Martinez-Gonzalez%20MA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMiguel%2BAngel%2BMartinez-Gonzalez%2B) Jordi Salas-Salvado 5 Universitat Rovira i Virgili; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jordi%2BSalas-Salvado%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Salas-Salvado%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJordi%2BSalas-Salvado%2B) * [ORCID record for Jordi Salas-Salvado](http://orcid.org/0000-0003-2700-7459 "Open in new tab") Ramon Estruch 6 Hospital Clinic de Barcelona; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ramon%2BEstruch%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Estruch%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARamon%2BEstruch%2B) Emilio Ros 7 August Pi i Sunyer Biomedical Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Emilio%2BRos%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ros%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEmilio%2BRos%2B) Raquel Cueto-Galan 8 University of Malaga; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Raquel%2BCueto-Galan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cueto-Galan%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARaquel%2BCueto-Galan%2B) Miquel Fiol 9 Hospital Son Espases; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Miquel%2BFiol%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fiol%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMiquel%2BFiol%2B) Jose Lapetra 10 Distrito Sanitario Atencion Primaria Sevilla; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jose%2BLapetra%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lapetra%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJose%2BLapetra%2B) Juan Timiraos 11 Hospital Universitario de Alava; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Juan%2BTimiraos%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Timiraos%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJuan%2BTimiraos%2B) Lluis Serra-Majem 12 Universidad de Las Palmas de Gran Canaria; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lluis%2BSerra-Majem%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Serra-Majem%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALluis%2BSerra-Majem%2B) Xavier Pinto 13 Hospital Universitari de Bellvitge; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Xavier%2BPinto%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pinto%20X&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AXavier%2BPinto%2B) Zenaida Vazquez-Ruiz 14 Universidad de Navarra; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zenaida%2BVazquez-Ruiz%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Vazquez-Ruiz%20Z&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AZenaida%2BVazquez-Ruiz%2B) Francisco Javier Martin-Lujan 15 Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Francisco%2BJavier%2BMartin-Lujan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Martin-Lujan%20FJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFrancisco%2BJavier%2BMartin-Lujan%2B) Montserrat Fito 1 Hospital del Mar Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Montserrat%2BFito%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fito%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMontserrat%2BFito%2B) Alvaro Hernaez 1 Hospital del Mar Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alvaro%2BHernaez%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hernaez%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlvaro%2BHernaez%2B) * [ORCID record for Alvaro Hernaez](http://orcid.org/0000-0001-8593-1477 "Open in new tab") * For correspondence: ahernaez@researchmar.net * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1300610/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1300610/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1300610/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1300610/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1300610/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1300610/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Objective: To investigate the association between usual moderate-to-vigorous leisure-time physical activity (MVLTPA) and longitudinal trajectories of BMI and waist-to-height ratio (WHtR), as well as the incidence of obesity (BMI >=30 kg/m2) and central adiposity (WHtR >=0.6), in older adults at high cardiovascular risk. Methods: In PREDIMED participants aged 60-80 years (61% women; n=5,273 for BMI, n=4,940 for WHtR), MVLTPA was assessed using the Minnesota questionnaire (MET-min/day, cumulative mean). Mixed-effects models with cubic splines were used to estimate BMI and WHtR trajectories according to MVLTPA levels (>=100 [adequate] vs =100 MET-min/day showed lower BMI and WHtR values compared with less active individuals (differences ranging from -1.27 to -1.48 kg/m2 and -0.021 to -0.026, respectively), and slower declines in BMI. Adequate MVLTPA was associated with a 34% lower risk of central adiposity (HR 0.66 [0.56; 0.77]) and a 24% lower risk of obesity only in women (HR 0.76 [0.57; 1.00], p-interaction = 0.084). Nonlinear analyses suggested that central adiposity risk decreased up to 400 MET-min/day and plateaued thereafter. Conclusions: Higher MVLTPA is associated with favourable adiposity trajectories and lower central adiposity risk in older adults at high cardiovascular risk. ### Competing Interest Statement E.R. reports personal fees, grants, and nonfinancial support from the California Walnut Commission and Alexion, and nonfinancial support from the International Nut Council. J.S.-S. reports being a board member and receiving personal fees from Instituto Danone Spain, and being a board member and receiving grants from the International Nut and Dried Fruit Foundation. R.E. reports being a board member of the Research Foundation on Wine and Nutrition, the Beer and Health Foundation, and the European Foundation for Alcohol Research; receiving personal fees from KAO Corporation; receiving lecture fees from Instituto Cervantes, Fundacion Dieta Mediterranea, Cerveceros de Espana, Lilly Laboratories, AstraZeneca, and Sanofi; and receiving grants from Novartis, Amgen, Bicentury, and Grand Fontaine. All other authors declare no conflicts of interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was conducted in accordance with the principles of the Declaration of Helsinki. The protocol was approved by the Ethics Committee of Parc de Salut Mar (reference 2024/11670/I; November 18, 2024). All participants provided written informed consent before enrolment in the PREDIMED study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Because national data-protection legislation and ethical restrictions prohibit public dissemination of the individual-level PREDIMED dataset, and because participants did not provide explicit written consent for open data sharing, the study dataset cannot be deposited in a public repository. Access to data for bona fide collaborative research may be facilitated for qualified investigators upon reasonable request and approval by the PREDIMED Steering Committee. Requests should be addressed to: predimed-steering-committee{at}googlegroups.com. The code used for constructing the database, managing the data, and performing the statistical analyses is openly available at: https://github.com/alvarohernaez/MVLTPA_cardiometab_PREDIMED. ## Funder Information Declared European Commission Generalitat de Catalunya, https://ror.org/01bg62x04, 2021 SGR 00144 Instituto de Salud Carlos III, https://ror.org/00ca2c886, PI24/00182, FI25/00006, CB16/11/00229 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.14.26362991v1 "Short-term postprandial glucose monitoring reveals stable traits from noisy free-living meals")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.14.26362981v1 "Lysosomal polygenic risk score in Parkinson's disease across populations.") Posted September 15, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/15/2026.09.14.26362982.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.09.14.26362982v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/15/2026.09.14.26362982.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Moderate-to-vigorous physical activity, age-dependent adiposity, and obesity risk in older adults at high cardiovascular risk Eleonora Fornara, Marta H Hernandez, Alberto Goday, Anna Camps-Vilaro, Miguel Angel Martinez-Gonzalez, Jordi Salas-Salvado, Ramon Estruch, Emilio Ros, Raquel Cueto-Galan, Miquel Fiol, Jose Lapetra, Juan Timiraos, Lluis Serra-Majem, Xavier Pinto, Zenaida Vazquez-Ruiz, Francisco Javier Martin-Lujan, Montserrat Fito, Alvaro Hernaez medRxiv 2026.09.14.26362982; doi: https://doi.org/10.64898/2026.09.14.26362982 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](http
## Related Clinical Research

- [Waist circumference predicts mortality more than BMI in adults 65+: study findings](https://medichelpline.com/clinical-feed/medical-news-today-0-bmi-vs-waist-size-study-finds-belly-fat-matters-more-than-weight-for-death-risk.md)
- [Sprint intervals boost heart-protective proteins more than moderate cycling, study finds](https://medichelpline.com/clinical-feed/medical-news-today-0-sprints-or-endurance-study-finds-short-workouts-release-heart-protective.md)
- [Orexin agonist ALKS 7290 shows ADHD symptom improvement in early Phase 1 trial](https://medichelpline.com/clinical-feed/stat-news-0-stat-alkermes-orexin-agonist-shows-potential-to-treat-adhd-in-early-stage-trial.md)
- [Two scientists to receive 2026 Ralph L. Sacco Scholarships for Brain Health](https://medichelpline.com/clinical-feed/aha-news-8-two-scientists-to-receive-2026-ralph-l-sacco-scholarships-for-brain-health.md)
- [FDA approves Fayuvi gene therapy for Sanfilippo syndrome type A — first approved treatment](https://medichelpline.com/clinical-feed/stat-news-2-stat-fda-approves-a-new-gene-therapy-for-sanfilippo-syndrome-an-ultra-rare.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.